In brief

BMJ 2004; 328 doi: (Published 29 January 2004) Cite this as: BMJ 2004;328:244

Spanish court dismisses drug company case: A Madrid court this week dismissed the demand for “rectification” brought against one of Spain's independent drug bulletins, Butlletí Groc, by Merck Sharp & Dohme. The bulletin had claimed in an article that the company had committed scientific fraud in a trial of its cyclo-oxygenase-2 (COX 2) inhibitor rofecoxib (Vioxx) (24 January, p 188). …

View Full Text

Log in

Log in through your institution


* For online subscription